HIV/AIDS Adverse Drug Reaction
Reactive metabolites cause drug reactions to sulfonamides in HIV infection
Published in AIDS Weekly, April 25th, 2005
According to a study from Canada, "Hypersensitivity adverse drug reactions are much more common among patients with acquired immunodeficiency syndrome (AIDS) than in the general population. High rates of hypersensitivity reactions to clindamycin have been noted.
"To investigate the role of reactive metabolites in these reactions, the authors studied toxicity of clindamycin and sulphamethoxazole (SMX) and their metabolites in uninfected and human immunodeficiency virus (HIV)-infected MOLT3 cells."
"Infected and uninfected cells were incubated with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2005-04-25)
More Articles from AIDS Weekly
- HIV/AIDS HAART Monitoring
Less expensive alternatives to viral load test demonstrate same HAART trends - HIV/AIDS Long-Term Nonprogressor
HIV-1 long-term nonprogressor subset characterized by ancestral sequences - HIV/AIDS Metabolism
Reducing HIV RNA improves muscle amino acid metabolism - HIV/AIDS Pathogenesis
T cell activation in HIV infection higher in Uganda than Western countries - HIV/AIDS-Related Dyslipidemia
HAART reduces VLDL and IDL apoB catabolic rate in patients with dyslipidemia - Adverse Drug Reaction
Effects of prenatal exposure to AZT on CNS investigated - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
